DAC NO.: HDAC004400
DAC name: Neoadjuvant in NSCLC
Contact person: Zhang Xian
URL:
Description: Phase II Trial of Neoadjuvant Camrelizumab and Apatinib in Patients with Resectable Non-Small-Cell Lung Cancer: Survival and Dynamic Circulating Tumor DNA Analyses
